These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. Allen KB; Dowling RD; Fudge TL; Schoettle GP; Selinger SL; Gangahar DM; Angell WW; Petracek MR; Shaar CJ; O'Neill WW N Engl J Med; 1999 Sep; 341(14):1029-36. PubMed ID: 10502592 [TBL] [Abstract][Full Text] [Related]
31. Percutaneous laser revascularization does not equal transmyocardial laser revascularization. Horvath KA J Am Coll Cardiol; 2006 Dec; 48(11):2354; author reply 2355. PubMed ID: 17161272 [No Abstract] [Full Text] [Related]
32. Surgical measures for coronary heart disease (first of three parts). Mundth ED; Austen WG N Engl J Med; 1975 Jul; 293(1):13-9. PubMed ID: 1093029 [No Abstract] [Full Text] [Related]
33. Use of magnetic resonance imaging to assess myocardial perfusion after transmyocardial laser revascularization. Akay MH; Cheong BY; Frazier OH Heart Surg Forum; 2009 Aug; 12(4):E199-201. PubMed ID: 19683988 [TBL] [Abstract][Full Text] [Related]
34. Technetium 99m-labeled tetrofosmin and iodine 123-labeled metaiodobenzylguanidine scintigraphy in the assessment of transmyocardial laser revascularization. Muxí A; Magriñá J; Martín F; Josa M; Fuster D; Setoain FJ; Pérez-Villa F; Pavía J; Bosch X J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1493-8. PubMed ID: 12830071 [TBL] [Abstract][Full Text] [Related]
35. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439 [TBL] [Abstract][Full Text] [Related]
36. Thoracoscopic transmyocardial laser revascularization. Horvath KA Ann Thorac Surg; 1998 May; 65(5):1439-41. PubMed ID: 9594882 [TBL] [Abstract][Full Text] [Related]
37. An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial. de Vries J; DeJongste MJ; Tio RA Eur Heart J; 2006 Jul; 27(13):1631-2; author reply 1632. PubMed ID: 16751209 [No Abstract] [Full Text] [Related]
39. Continued symptomatic improvement three to five years after transmyocardial revascularization with CO(2) laser: a late clinical follow-up of the Norwegian Randomized trial with transmyocardial revascularization. Aaberge L; Rootwelt K; Blomhoff S; Saatvedt K; Abdelnoor M; Forfang K J Am Coll Cardiol; 2002 May; 39(10):1588-93. PubMed ID: 12020484 [TBL] [Abstract][Full Text] [Related]
40. [Transmyocardial laser treatment--a new treatment modality in pronounced angina pectoris?]. Tjomsland O; Almdahl SM; Saatvedt K; Nordstrand K; Aaberge L Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3597-601. PubMed ID: 10563178 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]